Introduction
Hemovigilance during blood donation (BD) has been receiving increasing attention [1] [2] [3] [4] . The European Guide to preparation, use and quality assurance of blood components Diekamp/Gneißl/Rabe/Kießig few reports have focused on the safety concerns of preparatory plasmapheresis (PPP) [13] [14] [15] [16] , and these have often been abstracts [17] [18] [19] or case reports [20] ; only 1 older report considered PPP-related UEs [21] . Heuft et al. [22] have started a national, web-based system to assess UEs during or after cell separator procedures. The International Society of Blood Transfusion (ISBT) and the European Hemovigilance Network (EHN) advanced a system for documenting UEs during BD and hemapheresis procedures [23] . It provided 5 codes for hemapheresis-related problems, for citrate reaction, hemolysis, generalized allergic reaction, and air embolus. In our view, this does not cover the scope of UEs that we have observed regularly during PPP, particularly its technical problems. After 3.5 years, we summarize our experience with a computer-assisted UE system for all facets of UEs seen among 1,300 donors served daily.
Material and Methods
E.B.P.S.-Logistics (EBPS) developed and maintained a plasma management software (PMS) based on a SQL (structured query language) database. In 2003, the first version of the PMS-UE-documentation system was established in 6 donor centers [24] . Its objective was to document all local, systemic, and technical problems, side effects, untoward occurrences, and operator errors accompanying a donation process, including those resulting in broken-off collections (BOC). An update on January 1, 2008 included 3 grades of severity for each of 4 local and 5 systemic UE categories. 9 technical UEs were not graded for severity (tables 1, 2). 2 new donor centers were added when they opened in December 2008 and January 2009. During donor registration and processing, donor and donation data were entered into the PMS. Thus, all information about a donor and his former donations was available on-line at every work station.
Definition of a UE
A UE was defined as any occurrence locally at the venipuncture site or systemically adversely affecting the donor's wellbeing shortly before, during or within 24 (48-72) h after donation, as well as any technical problem related to equipment, staff and/or environment and impairing the procedure. The time frame of 24 h after donation was extended for local UEs, which took time to develop or to become evident. The physician determined causal relationship to donation. The principles for grading severity of local and systemic UEs are shown in table 1. To help distinguish UEs of mild from those of moderate degree, they include subjective criteria rather than limiting grading strictly to measured criteria.
UE Recording
If a UE occurred, donor room staff and/or the physician manually recorded the following on the donation protocol: collection status at UE onset, donor complaints, signs and symptoms, vital signs, physical findings, technical aspects of the UE, therapeutic measures, their effects, time to recovery, and donor status at release by the physician. The physician assigned the appropriate category, code and severity-grade and transferred all UE information to the PMS-UE module.
UE Documentation in the UE Module
By scanning the donor barcode on the donation protocol, the physician could open the PMS-macro with all identifying information. After opening the UE-module by mouse click, 5 more clicks entered an UE. Click 6 allowed a brief description of the UE to be entered. If the UE was of grade 3, a 7th step was required -the physician had to contact the donor for follow-up within 24 h of a systemic grade 3 UE (possibly later in case of a local grade 3 UE).
Multiple UEs during a Single Donation
Multiple UEs during a single donation were recorded in the appropriate categories as separate UEs rather than as singular UE to facilitate computer-assisted evaluation. Multiple UEs within a single donation were crossreferenced by their codes. A ratio (number of all UEs / donations associated with UEs) was used as an indicator of documentation accuracy, reflecting the proportion between single and multiple UEs with a singular donation.
UE Data Review and Trend Analysis
Quarterly, the medical director evaluated and corrected all UEs for clarity, code assignment, completeness, plausibility and cross-referencing. Summaries of 14 quarters between January 1, 2008 and June 30, 2011 served as basis for calculating UE-incidence rates.
Donor Database
For epidemiological analysis, EBPS compiled the data from the 8 centers, including: data on donors, numbers and types of donations, donor status, groups of gender, age and of body weight, their respective UE rates, data on multiple UEs at the same donation, and of donors with UEs at several donations.
We used the Fenwal Autopheresis C A200 apparatus (Fenwal Inc., Lake Zurich, IL, USA). Depending on donor body weight, we collected Donor Hemovigilance during Preparatory Plasmapheresis Table 2 lists UEs by major and sub-categories, codes, definitions of the specific features and grades of severity based on specific signs and symptoms, vital signs, technical aspects, therapeutic measures taken, and time needed for recovery; technical UE definitions are also specified there. Table 3 presents details on donors and their donations with and without UEs. 95.6% of PPP proceeded without any UEs. 48% of donors never experienced a UE, while 25% experienced them repeatedly. While only 1.2% of PPP were associated with more than 1 UE, 27% of UE-associated PPP had several UEs with the same donation. Table 4 relates donation frequency to yield and UE incidence. Whereas first or second time PPP donors had associated UEs very frequently (29 and 19%, respectively), the 660, 760 or 860 ml plasma in order to maintain extracorporeal volume < 15%. At the end of collection, the disposable system was rinsed with 500 ml saline to be infused into the donor, limiting red cell loss to 0.7 ml per PPP. Hemoglobin was measured photometrically in a capillary blood sample by an azide-methemoglobin method using HemoCue Hb 201 DM (HemoCue GmbH, Grossostheim, Germany) [25] . Minimal hemoglobin levels for donor eligibility for males was > 8.4 mmol/l and for females > 7.8 mmol/l.
Statistical Analysis
The statistical analysis was carried out by MedCalc using the comparison of proportions. The test performed a Chi-square test for the comparison of 2 proportions (from independent samples), expressed as a percentage [26] . Where the calculated p value was less than 0.05, the conclusion was that the 2 proportions were significantly different. The chi-square test Yates' correction for continuity was applied and those p values were 2-sided (or 2-tailed). (table 5) , 95% were small circumscribed hematomas at the venipuncture site; these UEs were common (1.27%), more so with inexperienced donors. We observed 1 instance of severe nerve injury and 9 cases of severe thrombophlebitis or lymphangitis.
Of the systemic UEs (table 5) , 93% of citrate reactions were mild. Overall, systemic UEs in first and second PPP were 19-fold and 8-fold higher than in 3 PPP. 79% of dona-UE incidence gradually decreased to below 3% as donors gained experience. The overall uncorrected UE incidence was 5.9%. The single to multiple UE ratio with a single donation remained fairly constant around 1.4 for the first 10 PPP; with growing donor experience, the ratio dropped to 1.3 UEs per PPP. Figure 1 compares the incidence of major UE categories and their sub-categories according to donor status as first-, second-or multiple-time ( 3) donor. Local and technical UEs occurred with similar incidence among first-and second-time complete return of red cells due to another specified cause (T-RR) accounted each for >15% of technical UEs. Machine failure or environmental problems (T-MF), T-SD, and operator error in programming or set assembling (T-OE) did not vary with donor status. BOC due to poor donor compliance (T-DC and T-LP) related more to new donors. Figure 3 shows quarterly UE incidences of the 3 major categories. Systemic UEs were stable throughout the study period. Local UEs decreased with introduction of the technical category T-RP in the third quarter of 2010, while technical UEs increased correspondingly. Table 6 shows the most frequent UE combinations seen with the same donation by donor status: donations with multiple events related most often to venous access problems and small hematomas, irrespective of donor status. Table 7 shows incidence and causes of BOC by donor status; 97% of all PPP were complete. The highest BOC incidence pertained to the first PPP. More than 90% of BOC were due to technical difficulties, mostly venous access problems. Table 8 shows the distribution of parameters that defined grade 3 systemic reactions with 399 PPP (357 CR-3 and 42 VR-3). Common parameters of severe systemic reactions were loss of consciousness, vomiting, syncope, severe circulatory insufficiency outside of donor center, and convulsions. 24% of donors with grade 3 reactions were male (26% of them first-time donors). tions with hypovolemic reactions (CRs) were complete: either the donors responded quickly to therapeutic measures, taken so that the procedure could be continued, or the reactions occurred near or after the end of collection. Hypovolemic reactions represented 78% of all systemic reactions. We defined psychogenic vasovagal reactions (VRs) as part of the early donation process or even preceding it; nevertheless, in more than 50%, collection was completed after supportive therapy (VR-1: 100%, VR-2: 26%, and VR-3: 12%). They accompanied first PPP 29-fold more frequently than 3 donations.
Severe systemic reactions (CR-3, VR-3, moderate hypertensive circulatory reaction (XH-2), severe cardiopulmonary complications (XC-3) and rare severe complications not otherwise specified (XR-3)) had an incidence of 0.04%, again with significant differences according to donor status. XH-2 were very rare. XC-3 UEs occurred in 3 donors: 1 had angina pectoris, 1 with had myocardial infarction, and 1 had sudden supraventricular tachycardia. All 3 donors recovered uneventfully.
Considering technical UEs ( fig. 2 ), 42% concerned problems with establishing or maintaining venous access (repeated venipuncture (failing to establish/maintain blood flow, T-RP) and BOC due to venous access problem (T-VA)), with significant differences according to donor status. These two subcategories were seen in 1.5% of all donations. Defective disposables (T-SD), BOC due to lipemic plasma (T-LP), and in- tions, 0.08% citrate toxicity and 0.4% local injuries. Our findings indicate that UEs are more common. In the literature, we found no accounts of UE rates seen with the second donation. Our data showed that the first and second PPP were commonly associated with high UE incidence. This indicates that the possible effectiveness of special care for inexperienced PPP donors (as provided for first BD) should be evaluated. Considering local UEs, small circumscribed hematomas may not have great significance for BD, where the donation interval must exceed 8 weeks. By that time, donors have likely forgotten the small nuisance in the bend of the elbow after their last donation. 87% of our local and systemic UEs were graded as mild. Yet, we considered them significant, as they may affect whether the donor returns: 31% of our donors donated only 1-5 times, contributing only 2.9% of all donations. These low frequency donors experienced 11% of all UEs (table 4). Newman et al. [35] elucidated, through post-donation interviews of BD donors, a substantial drop of donor return rates even after mild local and systemic UEs such as small hematomas, sore arm, fatigue, and/or circulatory donor reaction. Others also established a relationship of mild donor reactions after BD to a lesser likelihood of donor return [36] [37] [38] [39] [40] . Although frequent PPP donations at short intervals provided good feedback on local and systemic UEs occurring after leaving the center, there is 1 limitation to our analysis: we did not obtain systematical post-donation UE feedback from non-returning donors. With respect to PPP, the significance of mild hematomas must be emphasized: a donor with hematomas presenting within days for his next PPP had a problem -especially if both arms were affected. We would never access a vein through an old hematoma.
Distinction of injuries to nerves from those to veins and perivascular tissues was at times difficult if based strictly on clinical grounds: a direct injury of a nerve may have caused pain similar to the pain evoked by a rapidly developing hematoma with pressure on perinervous tissues. For nerve injury, it was decided that their radiating distally from the site of venipuncture was an essential criterion to distinguish them from injuries to the veins and perivascular tissues; symptoms from the latter were considered to be limited to the site of venipuncture and/or to radiate proximally.
For systemic UEs, signs and symptoms of citrate toxicity were rare with PPP, and at times difficult to distinguish from brief hyperventilation that may accompany vasovagal reactions [9] . Therefore, a separate hyperventilation category was not established.
Vasovagal reactions occurred mostly prior to, or within a few minutes after, the start of donation before a significant reduction of circulating blood volume took place [41] . Hypotensive reaction, sometimes referred to as 'delayed vasovagal reaction' [23] , is mostly due to hypovolemia, typically occurring in the recovery lounge after a BD. We consider hypovolemia as the main causative factor for a hypovolemic reaction once the donated product volume has exceeded 350 ml. The Discussion Analysis of our first PMS UE-documentation module revealed that UEs were frequently associated with PPP (5.6%) [24] . However, this earlier system did not meet the subsequent requirements of the government authorities for documenting UEs by severity and for reporting the most severe UEs of the donors. The system presented here remedied that deficit [5] .
Database
As of December 2, 2008, authorities requested that EBPS combine donor data from all PMS centers into a single database. 1,002 individuals registered in >1 center (1.7% of all donors). Data regarding status of such multiply registered donors as first-time, second-or multiple-( 3) time donors were not corrected for this analysis. Thus, some of these individuals could possibly account for first donations in several centers. As they contributed only 1.4% of all PPP, their effect on the UE-incidence rates was considered negligible.
There were differences in the numbers of local UEs obtained from the UE modules and those obtained from the EBPS, in part due to record unification as described, and in part due to a change in defining a donation only after a minimum of 50 ml was collected, effective from January 1, 2011. The blood centers continued to count all venipunctures performed after clearance of a donor as a donation, even if unsuccessful or none or only a few milliliters were collected. Thus, the EBPS compiled 1,921 (2.9%) PPP-UEs less than UEs compiled by the blood centers. We used blood center data for calculating UE incidence rates. For epidemiological information we had to rely on the data compiled by the EBPS. Retrospective reconciliation of these differences was not possible.
Documentation Process
Physicians required 2 min or less to enter 94% of all UEs (mild or technical) into the database. Moderate and severe UEs required more time because of the comments given. On starting the system, 10% documentation errors were found; in the meantime, the error rate has reached 2-5% of all UEs.
Our catalogue of local and systemic UEs corresponds to that established in the literature for BDs [5, 23] . Of course, issue could be taken with our UE definitions. Newman [27] presented a comprehensive review on donor reactions and injuries occurring as a result of a BD: overall, 11-21% of donors experienced a reaction or injury from BD, including 9-16% bruises or hematomas, 2-5% vasovagal symptoms and <0.5% other injuries or reaction. Generally accepted risk factors for systemic BD UEs were: first donation, young age, low body weight, female gender, fatigue, long waiting period, and crowded facility [27] [28] [29] [30] [31] [32] [33] . Up to now, comparable data with respect to PPP were largely unavailable [34] . The 210 UEs reported by Franchini et al. [15] with 19,565 PPP do not compare; they found the following UE rates: 0.6% vasovagal reac- Diekamp/Gneißl/Rabe/Kießig a hematoma at the site of a failed first attempt towards venous access necessitated a second venipuncture; initially, both had been documented as a single UE in the perivascular hemorrhage-1 (H-1) category. This did not offer the desired feedback for the phlebotomy team. Therefore, on 1 August 2010, a separate technical category for repeated venipuncture (T-RP) was introduced. For the corrected overall UE incidence, we applied the T-RP-and the H-1-incidence rates observed after that date. The introduction of a T-RP-category was a practical way to comply with the European regulations.
The catalogue of technical UEs is new to donor hemovigilance. Although Klein et al. [64] reviewed complications related to equipment and technique, their report dealt mainly with cytapheresis procedures. The economic implications of technical UEs are obvious, as they contribute to cost in terms of personnel time, supplies and lost donors [17] .
Donations with Multiple UEs
Of UE-associated PPP, 27% have multiple UEs at 1 donation. Common combinations are hematoma, repeated venipuncture, failure to establish/maintain venous access, and BOC with incomplete return of donor red cells. No other references to multiple UEs with the same donation could be found in the literature.
